The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Neuropsychiatric symptoms in Parkinson's disease
Open accessAbstract
Neuropsychiatric symptoms are common in Parkinson's disease, even at the earliest stages, and have important consequences for quality of life and daily functioning, are associated with increased carer burden and increased risk for nursing home admission. In addition to cognitive impairment, a wide range of neuropsychiatric symptoms have been reported. In this article, the epidemiology, clinical course, diagnosis, and management of some of the most common neuropsychiatric symptoms in PD are discussed: depression, anxiety, apathy, fatigue, and psychotic symptoms. Although much is known regarding the prevalence and course of these symptoms, the empirical evidence for how to manage these symptoms is limited at best. There is thus an urgent need for systematic studies for the pharmacological and non‐pharmacological management of these symptoms. © 2009 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Self-citationPrevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
Self-citationA systematic review of prevalence studies of depression in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Weber, W. E. J., Aarsland, D., & Leentjens, A. F. G. (2008) · Movement Disorders · doi:10.1002/mds.21803 · Cited by 1,239
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Self-citationReliability, validity, and clinical correlates of apathy in Parkinson's disease
(1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.2.134 · Cited by 1,185
Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,040
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00371-4 · Cited by 856
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06891.x · Cited by 811
Self-citationRisk factors for suicide in later life
Conwell, Y., Duberstein, P. R., & Caine, E. D. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01347-1 · Cited by 701
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
Shulman, L. M., Taback, R. L., Rabinstein, A. A., & Weiner, W. J. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00015-3 · Cited by 695
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 683
Self-citationLevy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., Paulsen, J. S., & Litvan, I. (1998) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.10.3.314 · Cited by 678
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Differential diagnosis and classification of apathy
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.1.22 · Cited by 620
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
(1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 615
Range of neuropsychiatric disturbances in patients with Parkinson's disease
Aarsland, D., Larsen, J. P., Lim, N. G., Janvin, C., Karlsen, K., Tandberg, E., & Cummings, J. L. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.492 · Cited by 581
Self-citationThe Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528 · cited 1×
“shop.(86) However, psychotic symptoms are not always reported voluntarily, and the clinician should ask for these phenomena.”
BackgroundSelf-citationAtypical antipsychotics for aggression and psychosis in Alzheimer's disease
Ballard, C. G., Waite, J., & Birks, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003476.pub2 · Cited by 525
Thobois, S., Ardouin, C., Lhommee, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Coelho Braga, M. C., Hassani, R., Kistner, A., et al. (2010) · Brain · doi:10.1093/brain/awq032 · Cited by 516
Miyasaki, J. M., Shannon, K., Voon, V., Ravina, B., Kleiner-Fisman, G., Anderson, K., Shulman, L. M., Gronseth, G., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000215428.46057.3d · Cited by 487
Pluck, G. C. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.636 · Cited by 473
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D’Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., et al. (2008) · Brain · doi:10.1093/brain/awn214 · Cited by 472
Aarsland, D., Ballard, C., Walker, Z., Bostrom, F., Alves, G., Kossakowski, K., Leroi, I., Pozo-Rodriguez, F., Minthon, L., & Londos, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70146-2 · Cited by 459
Self-citationHerlofson, K., & Larsen, J. P. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.02033.x · Cited by 441
Emre, M., Tsolaki, M., Bonuccelli, U., Destée, A., Tolosa, E., Kutzelnigg, A., Ceballos-Baumann, A., Zdravkovic, S., Bladström, A., & Jones, R. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70194-0 · Cited by 436
A controlled trial of antidepressants in patients with Parkinson disease and depression
Menza, M., Dobkin, R. D., Marin, H., Mark, M. H., Gara, M., Buyske, S., Bienfait, K., & Dicke, A. (2009) · Neurology · doi:10.1212/01.wnl.0000336340.89821.b3 · Cited by 414
Depression in Parkinson's disease: a quantitative and qualitative analysis.
Gotham, A. M., Brown, R. G., & Marsden, C. D. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.4.381 · Cited by 388
The nosological position of apathy in clinical practice
Starkstein, S. E., & Leentjens, A. F. G. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136895 · Cited by 371
Brown, R. G., Dittner, A., Findley, L., & Wessely, S. C. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.07.007 · Cited by 361
Fatigue in Parkinson's disease: A review
Friedman, J. H., Brown, R. G., Comella, C., Garber, C. E., Krupp, L. B., Lou, J., Marsh, L., Nail, L., Shulman, L., & Taylor, C. B. (2007) · Movement Disorders · doi:10.1002/mds.21240 · Cited by 356
Self-citationApathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations
Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., Starkstein, S. E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., et al. (2008) · Movement Disorders · doi:10.1002/mds.22229 · Cited by 346
Self-citationEpidemiology of psychosis in Parkinson's disease
Fénelon, G., & Alves, G. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.014 · Cited by 330
Marsh, L., McDonald, W. M., Cummings, J., Ravina, B., & NINDS/NIMH Work Group on Depression and Parkinson's Disease (2006) · Movement Disorders · doi:10.1002/mds.20723 · Cited by 318
Self-citationRochester, L., Hetherington, V., Jones, D., Nieuwboer, A., Willems, A.-M., Kwakkel, G., & Van Wegen, E. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.01.025 · Cited by 317
Parkinson's disease and anxiety: Comorbidity with depression
Menza, M. A., Robertson-Hoffman, D. E., & Bonapace, A. S. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90237-8 · Cited by 315
A systematic review of depression and mental illness preceding Parkinson's disease
Ishihara, L., & Brayne, C. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00579.x · Cited by 313
Hallucinations in Parkinson disease
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312
Burn, D., Emre, M., McKeith, I., De Deyn, P. P., Aarsland, D., Hsu, C., & Lane, R. (2006) · Movement Disorders · doi:10.1002/mds.21077 · Cited by 310
Self-citationRopinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease
Pahwa, R., Stacy, M. A., Factor, S. A., Lyons, K. E., Stocchi, F., Hersh, B. P., Elmer, L. W., Truong, D. D., & Earl, N. L. (2007) · Neurology · doi:10.1212/01.wnl.0000258660.74391.c1 · Cited by 290
Marinus, J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.241 · Cited by 288
Anxiety disorders in patients with Parkinson's disease
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.217 · Cited by 285
Dissociating apathy and depression in Parkinson disease
Kirsch-Darrow, L., Fernandez, H. F., Marsiske, M., Okun, M. S., & Bowers, D. (2006) · Neurology · doi:10.1212/01.wnl.0000230572.07791.22 · Cited by 284
The Rate of Cognitive Decline in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Perry, R., Wentzel-Larsen, T., Lolk, A., & Kragh-Sørensen, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1906 · Cited by 283
Self-citationAnxiety rating scales in Parkinson's disease: Critique and recommendations
Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., Starkstein, S. E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., et al. (2008) · Movement Disorders · doi:10.1002/mds.22233 · Cited by 275
Self-citationDevos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., Destée, A., Bordet, R., & Defebvre, L. (2008) · Movement Disorders · doi:10.1002/mds.21966 · Cited by 274
Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003) · Movement Disorders · doi:10.1002/mds.10390 · Cited by 272
Exacerbated physical fatigue and mental fatigue in Parkinson's disease
Lou, J., Kearns, G., Oken, B., Sexton, G., & Nutt, J. (2001) · Movement Disorders · doi:10.1002/mds.1042 · Cited by 244
Pacchetti, C., Manni, R., Zangaglia, R., Mancini, F., Marchioni, E., Tassorelli, C., Terzaghi, M., Ossola, M., Martignoni, E., Moglia, A., et al. (2005) · Movement Disorders · doi:10.1002/mds.20582 · Cited by 243
What contributes to depression in Parkinson's disease?
SCHRAG, A., JAHANSHAHI, M., & QUINN, N. P. (2001) · Psychological Medicine · doi:10.1017/s0033291799003141 · Cited by 242
Self-citationFatigue in patients with Parkinson's disease
Karlsen, K., Larsen, J. O., Tandberg, E., & J�rgensen, K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199903)14:2<237::aid-mds1006>3.0.co;2-x · Cited by 236
Longitudinal outcome of Parkinson’s disease patients with psychosis
Factor, S. A., Feustel, P. J., Friedman, J. H., Comella, C. L., Goetz, C. G., Kurlan, R., Parsa, M., Pfeiffer, R., & the Parkinson Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000068010.82167.cf · Cited by 234
Impulsive and compulsive behaviors in Parkinson's disease
Evans, A. H., Strafella, A. P., Weintraub, D., & Stacy, M. (2009) · Movement Disorders · doi:10.1002/mds.22505 · Cited by 233
Fatigue in Parkinson's disease
Friedman, J., & Friedman, H. (1993) · Neurology · doi:10.1212/wnl.43.10.2016 · Cited by 230
Fregni, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.027060 · Cited by 226
Characteristics of apathy in Parkinson's disease
Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destée, A., & Defebvre, L. (2007) · Movement Disorders · doi:10.1002/mds.21316 · Cited by 219
Is fatigue an independent and persistent symptom in patients with Parkinson disease?
Alves, G., Wentzel-Larsen, T., & Larsen, J. P. (2004) · Neurology · doi:10.1212/01.wnl.0000144277.06917.cc · Cited by 215
Quetiapine and Clozapine in Parkinsonian Patients With Dopaminergic Psychosis
Morgante, L., Epifanio, A., Spina, E., Zappia, M., Di Rosa, A. E., Marconi, R., Basile, G., Di Raimondo, G., La Spina, P., & Quattrone, A. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000136891.17006.ec · Cited by 214
Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease
Isella, V., Melzi, P., Grimaldi, M., Iurlaro, S., Piolti, R., Ferrarese, C., Frattola, L., & Appollonio, I. (2002) · Movement Disorders · doi:10.1002/mds.10041 · Cited by 212
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease: A Review
Zahodne, L. B., & Fernandez, H. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825080-00004 · Cited by 211
Recognition and Treatment of Depression in Parkinson's Disease
Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703256053 · Cited by 208
da Silva, T. M., Munhoz, R. P., Alvarez, C., Naliwaiko, K., Kiss, Á., Andreatini, R., & Ferraz, A. C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.008 · Cited by 205 · cited 1×
“A small placebo-controlled pilot trial recently reported significantly greater improvement of depression in patients treated with omega-3 fatty-acid supplementation.(46) Bright light therapy has also been reported to be slightly superior to placebo (with less bright light) in a trial.”
BackgroundPsychiatric aspects of Parkinson?s disease: An Update
Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200
Self-citationPsychiatric comorbidity in a population of Parkinson's disease patients
Nuti, A., Ceravolo, R., Piccinni, A., Dell'Agnello, G., Bellini, G., Gambaccini, G., Rossi, C., Logi, C., Dell'Osso, L., & Bonuccelli, U. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00781.x · Cited by 199
Maricle, R. A., Nutt, J. G., Valentine, R. J., & Carter, J. H. (1995) · Neurology · doi:10.1212/wnl.45.9.1757 · Cited by 197
Antidepressant studies in Parkinson's disease: A review and meta‐analysis
Weintraub, D., Morales, K. H., Moberg, P. J., Bilker, W. B., Balderston, C., Duda, J. E., Katz, I. R., & Stern, M. B. (2005) · Movement Disorders · doi:10.1002/mds.20555 · Cited by 191 · cited 1×
“There is a suggestion that antidepressant medications in PD are less effective than in depressed non-PD patients, although older patients and those with major depression may have a better response.(38) In one meta-analysis (11 studies, two placebo-controlled),(38) there was a large composite reduction in depression ra…”
ResultCharacteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies
Mosimann, U. P., Rowan, E. N., Partington, C. E., Collerton, D., Littlewood, E., O'Brien, J. T., Burn, D. J., & McKeith, I. G. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192480.89813.80 · Cited by 188
Scales to assess psychosis in Parkinson's disease: Critique and recommendations
Fernandez, H. H., Aarsland, D., Fénelon, G., Friedman, J. H., Marsh, L., Tröster, A. I., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., et al. (2008) · Movement Disorders · doi:10.1002/mds.21875 · Cited by 188
Self-citationThe Association of Ventral Tegmental Area Histopathology With Adult Dementia
Torack, R. M., & Morris, J. C. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290025008 · Cited by 185
Hallucinosis in idiopathic Parkinson's disease
Graham, J. M., Grunewald, R. A., & Sagar, H. J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.4.434 · Cited by 167
Bright light therapy in Parkinson's disease: a pilot study
Paus, S., Schmitz‐Hübsch, T., Wüllner, U., Vogel, A., Klockgether, T., & Abele, M. (2007) · Movement Disorders · doi:10.1002/mds.21542 · Cited by 162
Fatigue in levodopa-naïve subjects with Parkinson disease
Schifitto, G., Friedman, J. H., Oakes, D., Shulman, L., Comella, C. L., Marek, K., Fahn, S., & The Parkinson Study Group ELLDOPA Investigators (2008) · Neurology · doi:10.1212/01.wnl.0000324862.29733.69 · Cited by 160
An estimate of the incidence of dementia in idiopathic Parkinson's disease
Mayeux, R., Chen, J., Mirabello, E., Marder, K., Bell, K., Dooneief, G., Cote, L., & Stern, Y. (1990) · Neurology · doi:10.1212/wnl.40.10.1513 · Cited by 160
Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial
Mendonça, D. A., Menezes, K., & Jog, M. (2007) · Movement Disorders · doi:10.1002/mds.21656 · Cited by 150
Anxiety disorders in Parkinson's disease.
Richard, I. H. (2005) · PubMed · Cited by 147
"Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.
Vázquez, A., Jiménez-Jiménez, F. J., Ruiz, P., & García-Urra, D. (1993) · PubMed · Cited by 142
Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease
Nissenbaum, H., Quinn, N. P., Brown, R. G., Toone, B., Gotham, A.-M., & MARSDEN, C. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700000702 · Cited by 141
Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease
Soulas, T., Gurruchaga, J.-M., Palfi, S., Césaro, P., Nguyen, J. P., & Fénelon, G. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.130583 · Cited by 141
Effectiveness of ECT in Patients With Parkinsonism
Moellentine, C. K., Rummans, T. A., Ahlskog, J. E., Harmsen, W. S., Suman, V. J., O'Connor, M. K., Black, J. L., & Pileggi, T. S. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.2.187 · Cited by 139
Lou, J., Kearns, G. L., Benice, T. S., Oken, B., Sexton, G. J., & Nutt, J. G. (2003) · Movement Disorders · doi:10.1002/mds.10505 · Cited by 133
The efficacy and safety of ECT in depressed older adults: a literature review
van der Wurff, F. B., Stek, M. L., Hoogendijk, W. J. G., & Beekman, A. T. F. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.944 · Cited by 129
Physical activity and mental health
Stubbs, B., Vancampfort, D., Smith, L., Rosenbaum, S., Schuch, F. B., & Firth, J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30343-2 · Cited by 127
Ondo, W. G., Perkins, T., Swick, T. J., Hull, K. L., Jiménez, J., Garris, T. S., & Pardi, D. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1337 · Cited by 126
Factor, S. A., Friedman, J. H., Lannon, M. C., Oakes, D., Bourgeois, K. A., & The Parkinson Study Group (2001) · Movement Disorders · doi:10.1002/1531-8257(200101)16:1<135::aid-mds1006>3.0.co;2-q · Cited by 122
Suicidal and death ideation in Parkinson's disease
Nazem, S., Siderowf, A. D., Duda, J. E., Brown, G. K., Have, T. T., Stern, M. B., & Weintraub, D. A. (2008) · Movement Disorders · doi:10.1002/mds.22130 · Cited by 122
Hallucinations in Parkinson's disease: A follow‐up study
de Maindreville, A. D., Fénelon, G., & Mahieux, F. (2004) · Movement Disorders · doi:10.1002/mds.20263 · Cited by 119
Are Patients with Parkinson's Disease Suicidal?
Myslobodsky, M. S., Lalonde, F. M., & HICKS, L. H. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400304 · Cited by 114
Ballard, C. G., & Waite, J. (2006) · Research Portal (King's College London) · Cited by 112
Fatigue in Parkinson's disease
Friedman, J. H., Abrantes, A. M., & Sweet, L. H. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.587120 · Cited by 110
Anxiety and motor performance in parkinson's disease
Siemers, E., Shekhar, A., Quaid, K. A., & Dickson, H. (1993) · Movement Disorders · doi:10.1002/mds.870080415 · Cited by 107
Epstein, C. M., Evatt, M. L., Funk, A. P., Girard‐Siqueira, L., Lupei, N., Slaughter, L., Athar, S., Green, J., McDonald, W. M., & DeLong, M. R. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.07.010 · Cited by 102
A validation study of depressive syndromes in Parkinson's disease
STARKSTEIN, S. E., Merello, M., Jorge, R. E., Brockman, S., Bruce, D. G., Petracca, G., & Robinson, R. G. (2007) · Movement Disorders · doi:10.1002/mds.21866 · Cited by 98
Cardoso, E. F., Fregni, F., Maia, F. M., Boggio, P. S., Myczkowski, M. L., Coracini, K., Vieira, A. L., Melo, L. M., Sato, J. R., Marcolin, M. A., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007961 · Cited by 98
Impact of Fatigue in Parkinson’s Disease: The Fatigue Impact Scale for Daily Use (D-FIS)
Martínez‐Martín, P., Catalán, M. J., Benito‐León, J., Moreno, Á. O., Zamarbide, I., Cubo, E., van Blercon, N., Arillo, V. M. C., Pondal, M., Linazasoro, G., et al. (2006) · Quality of Life Research · doi:10.1007/s11136-005-4181-0 · Cited by 91
The "serotonin hypothesis" for depression in Parkinson's disease.
Mayeux, R. P. (1990) · PubMed · Cited by 87
Correlates of Generalized Anxiety and Panic Attacks in Dystonia and Parkinson Disease
Lauterbach, E. C., Freeman, A., & Vogel, R. L. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00004 · Cited by 82
Sleep and fatigue in Parkinson's disease
Friedman, J. H., & Chou, K. L. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.11.006 · Cited by 81
Differential DSM-III Psychiatric Disorder Prevalence Profiles in Dystonia and Parkinson's Disease
Lauterbach, E. C., Freeman, A., & Vogel, R. L. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.1.29 · Cited by 78
Evaluation of anxiety in Parkinson’s disease with some commonly used rating scales
Mondolo, F., Jahanshahi, M., Granà, A., Biasutti, E., Cacciatori, E., & Benedetto, P. D. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0834-9 · Cited by 75
Brønnick, K., Aarsland, D., & Larsen, J. P. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00562.x · Cited by 74
Self-citationCoping strategies for visual hallucinations in Parkinson's disease
Diederich, N. J., Pieri, V., & Goetz, C. G. (2003) · Movement Disorders · doi:10.1002/mds.10450 · Cited by 69
Increased Risk of Depressive and Anxiety Disorders in Relatives of Patients With Parkinson Disease
Arabia, G., Grossardt, B. R., Geda, Y. E., Carlin, J. M., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., & Rocca, W. A. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1385 · Cited by 69
Health-Related Quality of Life in Parkinson's Disease after Pallidotomy and Deep Brain Stimulation
Straits-Tröster, K. A., Fields, J. A., Wilkinson, S. B., Pahwa, R., Lyons, K. E., Koller, W. C., & Tröster, A. I. (2000) · Brain and Cognition · doi:10.1006/brcg.1999.1112 · Cited by 65
Differential Diagnosis of Apathy and Related Disorders of Diminished Motivation
Marin, R. S. (1997) · Psychiatric Annals · doi:10.3928/0048-5713-19970101-08 · Cited by 55
Cole, K., & Vaughan, F. L. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.03.002 · Cited by 49
Treatment Strategies in Amotivated Patients
Campbell, J. J., & Duffy, J. (1997) · Psychiatric Annals · doi:10.3928/0048-5713-19970101-11 · Cited by 44
Onofrj, M., Thomas, A., & Bonanni, L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1731 · Cited by 41
Social Security Disability Insurance (SSDI) in Parkinson's disease
Zesiewicz, T. A., Patel–Larson, A., Hauser, R. A., & Sullivan, K. L. (2007) · Disability and Rehabilitation · doi:10.1080/09638280701257247 · Cited by 37
Antidepressants in the Treatment of Psychosis With Comorbid Depression in Parkinson Disease
Voon, V., & Lang, A. E. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200403000-00009 · Cited by 34
Apathy in patients with Parkinson’s disease
Shulman, L. M. (2000) · International Review of Psychiatry · doi:10.1080/09540260020002523 · Cited by 30
The Effects of Antidepressants in Parkinson’s Disease: A Meta-Analysis
Frisina, P. G., Tenenbaum, H. R., Borod, J. C., & Foldi, N. S. (2008) · International Journal of Neuroscience · doi:10.1080/00207450701239418 · Cited by 30
Zahodne, L. B., & Fernandez, H. H. (2008) · CNS Spectrums · doi:10.1017/s1092852900017296 · Cited by 27
A controlled trial of antidepressants in patients with Parkinson’s disease and depression
Morgan, J. C., & Sethi, K. D. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0038-1 · Cited by 19
Suicide following deep brain stimulation for Parkinson's disease
Moriarty, J. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.151134 · Cited by 7
de Beurs, E., Wilson, K. A., Chambless, D. L., Goldstein, A. J., & Feske, U. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:4<140::aid-da2>3.0.co;2-g
Cited by
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Mhyre, T. R., Boyd, J. T., Hamill, R. W., & Maguire-Zeiss, K. A. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_16 · Cited by 423
Depression and Parkinson’s Disease: Current Knowledge
Marsh, L. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0409-5 · Cited by 404
Self-citationThe anatomy of apathy: a neurocognitive framework for amotivated behaviour
Le Heron, C., Apps., M. A. J., & Husain, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.07.003 · Cited by 380
“Apathy is common at all stages of the disease, is associated with impaired quality of life for both patients and their relatives, and is a presenting symptom in a significant number of cases (Aarsland et al., 2009).”
BackgroundAdult Neurogenesis in Neurodegenerative Diseases: Figure 1.
Winner, B., & Winkler, J. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021287 · Cited by 305
Metadata
- Authors
- Aarsland, D., Marsh, L., & Schrag, A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2009-09-18
- Volume
- 24
- Issue
- 15
- Pages
- 2175-2186
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2101206139
- Cited by
- 557
- References
- 121
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.